FOLFIRI-Bevacizumab Regimen

Preferred Label : FOLFIRI-Bevacizumab Regimen;

NCIt synonyms : Folinic Acid-Fluorouracil-Irinotecan-Bevacizumab Regimen; FOLFIRI-Avastin Regimen; FOLFIRI/Bevacizumab Regimen;

NCIt related terms : Bevacizumab IFL; FOLFIRI and Bevacizumab (L-Leucovorin); FOLFIRI and Bevacizumab;

NCIt definition : A regimen consisting of bevacizumab, fluorouracil, irinotecan and leucovorin that may be used in the treatment of ampullary and appendiceal adenocarcinoma, colorectal cancer, and small bowel adenocarcinoma.;

Alternative definition : NCI-GLOSS: A chemotherapy combination used as an initial treatment of colorectal cancer that has spread. It includes the drugs leucovorin (folinic acid), fluorouracil, irinotecan hydrochloride, and bevacizumab.;

NCIt note : Source: NCCN Guidelines and PDQ;

Codes from synonyms : CDR0000662508; CDR0000662509; 14656; 4391;

Details

Origin ID

C63608;

UMLS CUI

C1880657;

Est indiqué pour
- Rectal Carcinoma [NCIt concept]
- cancer of rectum [MeSH concept]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Bevacizumab [NCIt concept]
- Fluorouracil [NCIt concept]
- Irinotecan Hydrochloride [NCIt concept]
- Leucovorin Calcium [NCIt concept]
concept_is_in_subset
- CTRP Agent Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
- SEER Rx Interactive Antineoplastic Drugs Database [NCIt concept]
- SEER Rx Interactive Antineoplastic Drugs Database-Regimen [NCIt concept]
regimen_has_accepted_use_for_disease
- Colorectal Carcinoma [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients